FDA Expanded Access Programs for Experimental Medicines von Nightingale, Stuart L

Volltext

Emergency Use Authorization (EUA) to enable use of needed products in civilian and military emergencies, United States von Nightingale, Stuart L, Prasher, Joanna M, Simonson, Stewart

Volltext

Scientific Publication and Global Security von Nightingale, Stuart L

Volltext

Research Involving Human Subjects in Developing Countries von Koski, Greg, Nightingale, Stuart L

Volltext

Off-label use of prescription drugs von Nightingale, Stuart L

Volltext

Hypersensitivity to Chlorhexidine-Impregnated Medical Devices von Nightingale, Stuart L

Volltext

The role of the US Food and Drug Administration's patient information initiative in cost-effective drug therapy von Nightingale, S L, McGinnis, T J

Volltext

Editorial: Research involving human subjects in developing countries von Koski, Greg, Nightingale, Stuart L

Volltext

Trovafloxacin Public Health Advisory von Nightingale, Stuart L

Volltext

Hypotension and Bedside Leukocyte Reduction Filters von Nightingale, Stuart L

Volltext

Dietary Supplement Labeling More Informative von Nightingale, Stuart L

Volltext

Electronic "Orange Book" von Nightingale, Stuart L

Volltext

New Easy-to-Understand Labels for OTC Drugs von Nightingale, Stuart L

Volltext

Workshop on Medical Device Clinical Trial Development and Design von Nightingale, Stuart L

Volltext

Cerebyx Labels Changed von Nightingale, Stuart L

Volltext

Celecoxib for Arthritis von Nightingale, Stuart L

Volltext

Journal Editors Act to Enhance Reporting of Public Health Hazards von Nightingale, Stuart L

Volltext

Reporting Adverse Events and Product Problems Electronically von Nightingale, Stuart L

Volltext

FDA Conference on Human Subject Protection von Nightingale, Stuart L

Volltext

New Requirement for Patient Labeling for Selected Prescription Drug Products von Nightingale, Stuart L

Volltext